Aerosolized clindamycin is superior to aerosolized dexamethasone or clindamycin-dexamethasone combination in the treatment of severe Porphyromonas gingivalis aspiration pneumonia in an experimental murine model

REFERENCES

• Sibila O, Agusti C, Torres A: Corticosteroids in severe pneumonia. Eur Respir J. 2008;32:259–264.
   PubMed Web of Science ®Google Scholar
• Wunderink RG: Adjunctive therapy in community-acquired pneumonia. Semin Respir Crit Care Med. 2009;30:146–153.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.
   PubMed Web of Science ®Google Scholar
• Falguera M, Carratala J, Ruiz-Gonzalez A, Garcia-Vidal C, Gazquez I, Dorca J, : Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli. Respirology. 2009;14:105–111.
   PubMed Web of Science ®Google Scholar
• Paju S, Scannapieco FA: Oral biofilms, periodontitis, and pulmonary infections. Oral Dis. 2007;13:508–512.
   PubMed Web of Science ®Google Scholar
• Okuda K, Kimizuka R, Abe S, Kato T, Ishihara K: Involvement of periodontopathic anaerobes in aspiration pneumonia. J Periodontol. 2005;76:2154–2160.
   PubMed Web of Science ®Google Scholar
• Terpenning MS, Taylor GW, Lopatin DE, Kerr CK, Dominguez BL, Loesche WJ: Aspiration pneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc. 2001;49:557–563.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Wang M, Bagby GJ, Nelson S: Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice. J Immunol. 2008;181:4141–4149.
   PubMed Web of Science ®Google Scholar
• Gendron R, Grenier D, Maheu-Robert L: The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect. 2000;2:897–906.
   PubMed Web of Science ®Google Scholar
• Awano S, Ansai T, Takata Y, Soh I, Akifusa S, Hamasaki T, : Oral health and mortality risk from pneumonia in the elderly. J Dent Res. 2008;87:334–339.
   PubMed Web of Science ®Google Scholar
• Kimizuka R, Kato T, Ishihara K, Okuda K: Mixed infections with Porphyromonas gingivalis and Treponema denticola cause excessive inflammatory responses in a mouse pneumonia model compared with monoinfections. Microbes Infect. 2003;5:1357–1362.
   PubMed Web of Science ®Google Scholar
• Nemec A, Pavlica Z, Nemec-Svete A, Erzen D, Crossley DA, Petelin M: Lack of soluble tumor necrosis factor alpha receptor 1 and 2 and interleukin-1β compartmentalization in lungs of mice after a single intratracheal inoculation with live Porphyromonas gingivalis. Exp Lung Res. 2009;35:605–620.
   PubMed Web of Science ®Google Scholar
• Siempos II, Vardakas KZ, Kopterides P, Falagas ME: Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother. 2008;62:661–668.
   PubMed Web of Science ®Google Scholar
• Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG: Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181:975–982.
   PubMed Web of Science ®Google Scholar
• Wijagkanalan W, Higuchi Y, Kawakami S, Teshima M, Sasaki H, Hashida M: Enhanced anti-inflammation of inhaled dexamethasone palmitate using mannosylated liposomes in an endotoxin-induced lung inflammation model. Mol Pharmacol. 2008;74:1183–1192.
   PubMed Web of Science ®Google Scholar
• Mizgerd JP: Acute lower respiratory tract infection. N Engl J Med. 2008;358:716–727.
   PubMed Web of Science ®Google Scholar
• Pavlica Z, Nemec A, Nemec A, Eržen D, Crossley DA, Petelin M: Local and systemic up-regulation of TNFα, IL-1β and IL-6 in mice intratracheally inoculated with Porphyromonas gingivalis. Acta Vet Brno. 2008;77:377–385.
   Web of Science ®Google Scholar
• Tagliabue C, Salvatore CM, Techasaensiri C, Mejias A, Torres JP, Katz K, : The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection. J Infect Dis. 2008;198:1180–1188.
   PubMed Web of Science ®Google Scholar
• Hale KK, Smith CG, Baker SL, Vanderslice RW, Squires CH, Gleason TM, : Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Cytokine. 1995;7:26–38.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Hoidal JR, Mukherjee TK: Role of TNFalpha in pulmonary pathophysiology. Respir Res. 2006;7:125.
   PubMed Web of Science ®Google Scholar
• Agusti C, Rano A, Filella X, Gonzalez J, Moreno A, Xaubet A, : Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response. Chest. 2003;123:488–498.
   PubMed Web of Science ®Google Scholar
• Monton C, Ewig S, Torres A, El-Ebiary M, Filella X, Rano A, : Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J. 1999;14:218–220.
   PubMed Web of Science ®Google Scholar
• Sibila O, Luna CM, Agusti C, Baquero S, Gando S, Patron JR, : Effects of glucocorticoids in ventilated piglets with severe pneumonia. Eur Respir J. 2008;32:1037–1046.
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R, Manresa F, : Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect. 2009;15:1033–1038.
   PubMed Web of Science ®Google Scholar
• Yende S, D'Angelo G, Kellum JA, Weissfeld L, Fine J, Welch RD, : Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis. Am J Respir Crit Care Med. 2008;177:1242–1247.
   PubMed Web of Science ®Google Scholar
• Kulik EM, Lenkeit K, Chenaux S, Meyer J: Antimicrobial susceptibility of periodontopathogenic bacteria. J Antimicrob Chemother. 2008;61:1087–1091.
   PubMed Web of Science ®Google Scholar
• Ardila CM, Granada MI, Guzman IC: Antibiotic resistance of subgingival species in chronic periodontitis patients. J Periodontal Res. 2010;45:557–563.
   PubMed Web of Science ®Google Scholar
• Kadowaki M, Demura Y, Mizuno S, Uesaka D, Ameshima S, Miyamori I, : Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest. 2005;127:1276–1282.
   PubMed Web of Science ®Google Scholar
• Allewelt M, Schuler P, Bolcskei PL, Mauch H, Lode H: Ampicillin + sulbactam vs clindamycin +/− cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect. 2004;10:163–170.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Hirsch CS: Aspiration pneumonia. Recognizing and managing a potentially growing disorder. Postgrad Med. 2003;113:99–102, 105–106, 111–112.
   PubMed Web of Science ®Google Scholar
• Ioanas M, Ferrer M, Cavalcanti M, Ferrer R, Ewig S, Filella X, : Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia. Crit Care Med. 2004;32:938–945.
   PubMed Web of Science ®Google Scholar
• Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR: Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis. 1989;159:189–194.
   PubMed Web of Science ®Google Scholar
• Igonin AA, Armstrong VW, Shipkova M, Lazareva NB, Kukes VG, Oellerich M: Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Clin Biochem. 2004;37:204–209.
   PubMed Web of Science ®Google Scholar
• Deng JC, Standiford TJ: The systemic response to lung infection. Clin Chest Med. 2005;26:1–9.
   PubMed Web of Science ®Google Scholar
• Tutor JD, Mason CM, Dobard E, Beckerman RC, Summer WR, Nelson S: Loss of compartmentalization of alveolar tumor necrosis factor after lung injury. Am J Respir Crit Care Med. 1994;149:1107–1111.
   PubMed Web of Science ®Google Scholar
• Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, : The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J Immunol. 2010;184:836–843.
   PubMed Web of Science ®Google Scholar
• Di Paola R, Mazzon E, Muia C, Crisafulli C, Terrana D, Greco S, : Effects of etanercept, a tumour necrosis factor-alpha antagonist, in an experimental model of periodontitis in rats. Br J Pharmacol. 2007;150:286–297.
   PubMed Web of Science ®Google Scholar
• Yanik GA, Ho VT, Levine JE, White ES, Braun T, Antin JH, : The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood. 2008;112:3073–3081.
   PubMed Web of Science ®Google Scholar
• Patial S, Parameswaran N: Tumor necrosis factor-alpha signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20:87–103.
   PubMed Web of Science ®Google Scholar